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INTRODUCTION
“The relief of pain purchased is always at a price”
- R.M.Water’s
“For all the happiness mankind can gain is not in pleasure but in rest from pain” 
- John Dyrden
The aim of the anaesthesiology as a science is the removal of pain temporarily 
have been started initially with pain relief for surgeries, extending now to post operative 
pain relief and relief from chronic pain and cancer pain.
Spinal  anaesthesia  plays an  important  role  of  alleviating pain intraoperatively, 
extending into post operative period also.
The entry of corning’s needle in 1885 into subarachnoid space paved the way for 
the greatest leap into spinal anaesthesia. As a neurologist, corning’s objective was to 
relieve chronic pain in his patients, not to produce operative anaesthesia.
Cocaine was the drug first used experimentally in dogs. In men the first spinal 
anaesthesia was conducted by “August Bier” on 16.08.1898 with cocaine 3cc as 0.5% 
solution followed by “Rudolph matas” in America and “Theodore Tuffier” in France.
Spinal  anaesthesia  is  the  most  frequently  employed  anaesthetic  technique  for 
“TURP” and other cystoscopic urologic procedures. It provides an adequet anaesthesia 
for the patient and good relaxation of the pelvic floor and perineam for the surgeon. The 
complication of cystoscopic procedures can be easily recognized because of the patient 
is awake. Accidental bladder perforation also is recognized easily if the spinal level is 
limited to T10 as patient experience abdominal and shoulder pain.
ADVANTAGES:
Change in the mental status in a conscious patient can be detected early.
Sympathetic blockade produced by regional anaesthesia will increase the venous 
capacitance thereby decreasing the effect of fluid absorption.
Bladder  perforation  is  recognized  earlier.  Reduced  incidence  of  deep  vein 
thrombosis. Decreased requirement of analgesics in the immediate post operative period.
The demonstration of the opiate receptor in the substantia gelatinosa of the spinal 
cord (yaksh and Rudy-1976)  has created interest  in the intrathecal  administration of 
opiates.
The advantages of neuraxial opioids over neuraxial local anaesthetics are that it 
produces prolonged,intense and selective segmental analgesia without motor blockade 
and sympathetic dysfunction. 
Opioids and local  anaestheties  administered together  have a  potent  synergistic 
analgesic effect. Intrathecal opioids enhance analgesia from subtherapeutic dose of local 
anaesthetic and make it possible to achieve successful spinal anaesthesia using otherwise 
inadequate doses of local anesthetic.
Hence the present study has been under taken to combine “Fentanyl” a potent 
synthetic  opioid  and  “Bupivacaine”  a  long  acting  local  anesthetic  for  intrathecal 
administration  to  provide  anaesthesia  for  Endoscopic  urological  procedures  in  elder 
patients.
AIM OF THE STUDY
Regional anaesthesia is the most frequently employed anaesthetic technique for 
TURP and other endoscopic urologic procedures. These patients are mostly elderly with 
low cardiac reserve. The conventional dose of Bupivacaine may produce haemodynamic 
instability.  The  aim  of  my  study  is  to  find  out  the  minimum  effective  dose  of 
Bupivacaine with 25µg of fentanyl for spinal anaesthesia in elderly patients undergoing 
endoscopic  urologic procedures.
ANATOMY OF SUBARACHNOID SPACE
Subarachnoid  block  means  the  temporary  interruption  of  nerve  transminssion 
within the subarachnoid space produced by injection of a local anaesthetic solution into 
cerebrospinal fluid.
Applied anatomy of vertebral canal:
Vertebral canal extends from foramen magnum to the sacral hiatus. It protects the 
spinal cord.
The vertebral column comprised 33 vertebrae (7-cervical, 12-thoracic, 5-lumbar, 
5-fused sacral and 4-coccygeal) has four curves. Cervical and lumbar curves are convex 
anteriorly  and  thoracic  &  sacral  curves  are  convex  posteriorly.  The  curves  of  the 
vertebral  column  influences  the  spread  of  the  local  anaesthetic  in  the  subarachnoid 
space.
Each vertebra is  composed of  a body separated from the adjacent  vertebra by 
intervertebral disc and vertebral and formed by pedicles and laminae, which surround 
and protect the cord laterally and posteriosly.
The vertebral column is bound together by several ligaments. They are,
1. Supraspinal  ligament  –  passess  longitudinally  over  the  tips  of  the  spinous 
processes from C7 to the sacrum.
2. Interspinous ligament – connects the adjoining spinous processes together. 
3. Ligamentum Flavum – Known as yellow ligament, connects the adjacent laminae 
composed of yellow elastic fibres. They become progressively thicker from above 
downwards.
4. Posterior  longitudinal  ligament  –  It  is  on  the  posterior  surface  of  bodies  of 
vertebral.
5. Anterior longitudinal ligament – It runs along the front of the vertebral bodies.
There are seven projections from these vertebral (or) neural arches. They are,
a) Three muscular processes – (2-Transverse processes, 1-spinous process for the 
attachment of muscle and ligaments).
b) Four articular  process – Two upper & two lower  which in  the lumbar region 
prevent  rotation  but  allow  limited  flexion  and  extension  between  contiguous 
vertebrae.
Vertebral  canal  formed  by  these  structures  has  deficiencies  posteriorly  in  the 
midline called inter laminar foramina which enlarge in flexion accessible for the passage 
of  spinal  needle.  The  direction  of  spinous  process  determine  the direction  of  spinal 
needle.
SPINAL CORD:
It is the direct continuation of the medulla oblongata extending from the upper 
border of the atlas to the first lumber vertebra below which there is leash of nerve roots 
termed cauda equina. Spinal nerves are 31 pairs totally.
8 – Cervical
12 – Thoracic
5 – Lumbar
5 – Sacral
1 – Coccygeal         
Each of the spinal nerve is composed of anterior and posterior roots uniting at the 
inter vertebral foramina and form a nerve trunk. Membranes covering the spinal cord 
from without are dura mater, arachnoid mater and piamater. Dura and arachnoid mater 
end at S2 level. Piamater is closely applied to the spinal cord.
BLOOD SUPPLY:
It is from the anterior spinal artery which is a branch of vertebral artery and also 
by a pair of posterior spinal arteries which arise from the posterior inferior carebellar 
arteries. There is no anastamosis between these arteries.
SPINAL VEINS:
The spinal veins are arranged into anterior and posterior plexus which are draining 
into vertebral, azygos and lumbar veins.       
CEREBROSPINAL FLUIDS:
This is an ultrafiltrate of the blood plasma from choroids plexus of the lateral 
ventricles with a pH of 7.32 (7.27-7.37)
It is a clear, colourless fluid found in the cranial and spinal subarachnoid spaces 
and in the ventricle of the brain.
The total volume of CSF in an average adult ranges from 120-150ml of which 
25-35ml is in the spinal subarachnoid space.
Composition of cerebrospinal fluid:
Specific gravity - 1.006 (1.003-1.009) at 370C  
Pressure - 60-80mm of water
Pco2 - 48mmHg
HCo3- - 23meq/l
Na+ - 133-145meq/l
Ca+ - 2-3meq/l
Po4- - 1.6mg/dl
Mg+ - 2-2.5mg/l
cl- - 15-20weg/l
Protein - 23-38mg/dl
Sugar - 45-80mg/dl
Lymphocytes - 0-5cells/cmm
An important factor that determine the spread of drug in cerebrospinal fluid is the 
specific gravity of the drug in relation to that of cerebrospinal fluid (Baricity) which is 
1.003-1.009. Hyper baric solution is one which is denser than CSF at 370C. 
PHYSIOLOGY OF SUBARACHNOID BLOCK
Subarachnoid  block  implies  the  temporary  interruption  of  nerve  transmission 
within the subarachnoid space by injections of local anaethetics. The blockade of nerve 
fibres occur in the order of Temperature, Pain, proprioceptive and then motor fibres.  
FACTORS INFLUENCING BLOCK HEIGHT:
a - Site of injection 
b - Angulation of needle 
c - Characteristic of local anaesthetic
i) Density of local anaesthetic 
ii) Specific gravity
iii) Baricity
d - Dose of local anaesthetic
e - Position of the patient during and after injection
f - Anatomic configuration of spinal column.
g - Patient height (at extrems)
h - Volume of cerebrospinal fluid
i - Reduced cerebrospinal fluid with increased intra abdominal 
  pressure (eg. Pregnancy)
a) Effects on Cardio Vascular System:   
Most  important  physiological  responses  to  subarachnoid  block  involve  cardio 
vascular system due to combined effect of autonomic denervation, higher level of neural 
block, added effect of vagal innervation. 
Local  anaesthetics  and  vasoactive  substances  administered  in  small  doses 
intrathercally leads to direct cardiovascular effect.
Level  of sympathetic  denervation determines the magnitude of  cardio vascular 
system responses, but the relationship is neither predictable nor precise.
Sympathetic  denervation  produces  arterial  and  more  physiologically  important 
arteriolar dilatation and vasodilatation in the venous circulation produces fall in blood 
pressure.
Due to Bainbridge reflex, the fall in blood pressure is associated with bradycardia, 
blockade of cardiac sympathetic fibre from T1-T4 is an additional factor that causes 
bradycardia. 
b) Effects on Respiratory System:
Respiration  is  not  depressed  normally.  High  spinal  can  cause  paralysis  of 
intercostals muscles but resting tidal volume, maximum inspiratory volume, respiratory 
rate,  ABG, negative intrapleural  pressure  and also  the phrenic  nerve are  unaffected. 
Hypoxia may accompany hypotension and is corrected by oxygen administration via 
face mask.
c) Gastro Intestinal Effect:
Preganglionic fibres from T5-L1 are inhibitory to gut. So in sympathetic blockade 
the  small  intestine  contracts  with  relaxed  sphincters  and  peristalsis  remains  normal. 
Handling of viscera causes discomfort and brady cardia since vagus is not blocked.
d) Hepatic and Renal Effects:
The hepatic blood flow decreases and is directly proportional to the decrease in 
blood pressure. There may be normal hepatic oxygen extraction. Renal blood flow is 
maintained by autoregulation  and does  not  decrease  till  mean  arterial  pressure  goes 
below 50mmHg.
e) Genito Urinary System:          
Sphincters  of  bladder  are  not  relaxed,  and tone  ureter  are  not  greatly  altered. 
Urinary retension occurs. Penis is often engorged, and erigentes (S2, S3). Uterine tone is 
unchanged in pregnancy. In the absence of hypotension spinal anaesthesia has got no 
effect on the progress of labour and uterine blood flow. 
f) Metabolic and hormonal effect:
Spinal anaesthesia bocks hormonal and metabolic responses to nociceptive stimuli 
arising  from  the  operative  site.  It  minimizes  the  rise  in  blood  sugar,  coritsol, 
catecholamines  renin  and  aldosterone  release  associated  with  stress.  Post  operative 
negative nitrogen balance and secretion of antidiuretic hormone are inhibited. 
g) Thermo Regulation:
Hypothermia results from heat loss to the cold environment due to vasodilatation.
ANATOMICAL AND PHYSIOLOGICAL ANAESTHETIC 
IMPLICATIONS IN ELDER PATIENTS
There  is  no  standard  definition  of  elderly,  but  it  is  often  arbitrarily  taken  as 
morethan 65 years. They have an increased risk of morbidity and mortality associated 
with anaesthesia and surgery due to physiological changes of aging. 
a) Cardiovascular System:
 50-65% of patients have cardiovascular disease.
 Reduction  in  ventricular  compliance  due  to  myocardial  fibrosis  and  wall 
thickening.
 Systolic hypertension and widened pulse pressure
 Autonomic responses decreases.
 Increased capillary permeability leading to pulmonary oedema.
b) Respiratory System:
 Ventilatory responses to hypoxia and hypercarbia decreases. 
 Oxygen consumption and carbondioxide production fall by 10-15% by the 7th 
decades. 
 Lung  compliance  increases,  chest  wall  compliance  decreases.  Total  thoracic 
compliance decreases.
 Closing volume increases.
 Airway protective reflexes decreases leading to pulmonary aspiration.
 In edentulous patients face mask seal way be difficult.
c) Renal System:
 Decreased  Glomerular  filtration  rate,  decreased  creatinine  clearence,  tubular 
function reduces leading to reduced concentrating ability. 
 Clearance of renally excreted drugs are reduced necessitating dose adjustments.
d) Hepatic System:
 Cellular function is relatively well preserved in healthy patients.
 Hepatic mass and hepatic blood flow decreases.
e) Central Nervous System:
 Brain size and mass decreases, cortical atrophy, dementia affects 10% of patients 
over 65 years of age.
 They require lower dose of opioids and sedatives.
 Pain threshold may be increased.
 Post operative cognitive dysfunction is common.
 The thirst response to reduced extra cellular fluid volume and increased plasma 
osmolality is reduced in the elderly, increasing suseebtibility to fluid depletion. 
f) Pharmacology:
 Total  body  water  is  reduced,  fat  is  increased.  Arm brain  circulation  time  is 
prolonged.
 Reduced plasma albumine concentration decreases dose requirement.
 MAC of inhaled agents decreased. 
 Risk of Gastro intestinal tract bleed and acute renal failure due to nonsteroidal 
anti inflammatory drugs are increased.        
g) Thermoregulation:
Temperature regulation is impaired increasing the risk of hypothermia.
h) Endocrine:
Glucose loading is poorly tolerated.
i) Nutrition:
Nutrition status frequently poor.
j) Haematology:
Hyper  coagulability  and  deep  vein  thrombosis  become  more  common  with 
advancing age.    
ANAESTHETIC IMPLICATIONS OF ENDOSCOPIC UROLOGICAL 
PROCEDURE
Commonly performing endoscopic urological procedures in Government Rajaji 
Hospital, Madurai are the following.
a) TURP - 49.5%
b) TURBT - 13.5%
c) Vesicolithotripry - 11%
d) OIU - 17.5%
e) Others - 9%
Neuro anatomy of the penis prostate and urinary bladder:
Organ Sympathetic Parasympathetic Spinal levels of pain conduction 
Bladder T11-T12 S2-S4
T11-L2 (dome) S2-
S4 (neck)
Prostate T11-T12 S2-S4
T11-L2
S2-S4
Penis and urethra L1-L2 S2-S4 S2-S4
 
The afferent carrying sensations of stretch end of bladder are parasympathetic, 
where as pain, touch and temperature sensations are carried by the sympathetic nerves. 
Sympathetic fibres are predominantly α – adrenergic in the bladder base and urethra and 
β – adrenergic in the bladder dome and lateral wall.
The  majority  of  patients  are  undergoing  procedure  for  Benign  prostatic 
hypertrophy. The incidence increases over 60 years of age.
Spinal anaesthesia works well for rigid cystoseopic procedures, and is commonly 
used for Trans urethral resection of prostate. Sensory supply to the bladder is from T11 & 
T12 and urethra, prostate and bladder neck is from S2-S4. So block upto T11 is necessary 
for TURP Surgery.
Complications of TURP Surgery:
Bladder  distension  due  to  large  volume  of  irrigant  fluid  used  in  cystoscopic 
procedure is a potent stimulant to produce autonomic hyper reflexia. The complications 
of TURP surgery are mainly due to irrigation fluid used. 
i) TURP syndrome
ii) Haemorrhage
iii) Perforation of Bladder
iv) Hypothermia
v) Transient Bacteremia, Septicemia
vi) Transient Blindness
vii) Hyper ammonimia
TURP:
Combination  of  fluid  over  load  and  hyponatremia  due  to  large  volume  of 
irrigation fluid absorbed via open venous sinuses. 
About 20ml/mt and an average patients absorb a total of 1-1.5 litres. Amount of 
absorption depends on pressure of infusion venous pressure and duration of procedure.
Clinical Features:
 Restlessness,  head  ach,  Tachypenia,  respiratory  distress,  hypoxia,  nausea, 
vomiting, visual disturbance, confusion, convulsions & coma.
 Pulmonary oedema, Heart failure, cerebral oedema and hyponatremia.
Diagnosed by serum sodium level and arterial blood gas analysis:
Treatment:
 Reassure the patient
 Terminate the surgery as soon as possible.
 Switch over to normal saline for bladder irrigation.
 Administer injection furosemide 20mg intravenously 
 Administer oxygen through face work.
 If the patient develops pulmonary oedema intubate and give positive pressure 
ventilation. Invasive haemodynamic monitors may be needed.
 Draw arterial blood for arterial blood gas analysis and serum sodium estimation.
 Intra venous hypertonic saline (3% (or) 5%) may be needed if the hyponatremia 
present in the rate of 100ml/hour.
 Anti convulsant if the patient develops seizures.
 Transfuse packed red cell if blood loss is more. 
PHARMACOLOGY OF DRUGS
a) Bupivacaine:
Bupivacaine is  an amide linked local  anaesthetic.  It  is  a  hydrochloride salt  of 
d(1)-1-butyl 2’6’ pipecoloxylidide and is presented as a racemic mixture.
 It was synthesized by EO af Ekenstem.
 First reports of its use was published in 1963 by Telivuo.
 It  is  derived  from  Mepivacaine  and  is  very  stable  compound  and  may  be 
autoclaved repeatedly.
Pka is 8.1
MW - 288 
Protein biuding - 95%
Lipid solubility - 28
Ellimination half life - 210mts
Toxic plasma concentration - >1.5µg/ml
Approximate duration of action - 175mts
Availability:
Ampouls - 0.5% Bupivacaine hydrochloride 4cc
- 0.5% Bupivacaine hydrochloride with dextrose 
(heavy) 4cc
Vials - 0.25% and 0.5% Bupivacaine hydrochloride 20cc
Dosage - Maximum dosage 3mg/kg body weight.
Uses:
 Spinal anaesthesia
 Epidural anaesthesia
 Caudal anaesthesia
 Continuous epidural anaesthesia
 Peripheral nerve block
Onset time and duration of action
Site of action Onset (minutes) Duration (minutes)
Intrathecal 5 180-240
Epidural 15-20 165-225
Brachial plexus 15-20 600
Pharmacokinetics:
Once injected intra thecally, it gets absorbed by the nerve rootlets and results in 
the  desired  effect.  It  is  rapidly  absorbed  from the  site  of  injection,  but  the  rate  of 
absorption depends on the vascularity at the site and presence of vasoconstrictors.
High lipid solubility of bupivacaine makes it easy for nerve and vascular tissue 
penetration.
80-95% of the absorbed bupivacaive binds to the plasma.
Distribution:
Rapid distribution phase: (α)
In this phase the drug is distributed to highly vascular region t1/2% of α  - being 
2.7 minutes.     
Slow disappearance phase: (β)
In this phase the drug distributes to slowly equilibrating tissues t1/2 of β – being 
28mts. 
Biotransformation and excretion phase δ 
T1/2 of δ is 3.5hours clearance is 0.47 litre/minute.
Biotransformation:
Possible path ways of metabolism of bupivacaine include aromatic hydroxylation 
and conjugation. Only the N-dealkylated metabolite, N-desbutyl bupivacaine has been 
measured  in  blood  (or)  urine  after  epidural  (or)  spinal  anaesthesia.  Alpha1  acid 
glycoprotein is the most important plasma protein binding site of bupivacaine and its 
concentration is increased by many clinical situation including post operative trauma.
Exerction:
It is through the kidney, 4-10% of the drug is excreted unchanged.
Mode of Action:
a) Site of action:
i) The spinal nerve rootlet fine nerve filaments having a large surface area are 
exposed to the local anaesthetics. 
ii) Posterior and lateral aspects of the spinal cord itself.
b) Sodium Channel blockade:
They  impede  sodium  ion  access  to  the  axon  interior  by  occluding  the 
transmenbrane sodium channels thus delaying the process of depolarization and axon 
remains polarized. It is a non-depolarisation blockade.    
Pharmacodynamics:
It has got a longer duration of action but a slower onset.
Cardio vascular system:
It reduces cardiac output by reducing the sympathetic tone, by slowing the heart 
rate and by reducing the venous return, it produces a fall in arterial blood pressure but it 
is relatively slow and is seldom very profound.
It produces a fall in central venous pressure. It causes an increase in lower limb 
blood flow. It causes a reduction in incidence of deep vein thrombosis.
Respiratory System:
Spinal blockade seldom, if ever causes respiratory problem.
Gastro intestinal tract:
There  is  an  increase  in  gastro  intestinal  motility  and  emptying  of  the  gastric 
contents are better.  
 
Toxicity:
Toxicity is related to plasma level of unbound drug and more likely due to an 
inadverdant intravenous injection. Systemic toxicity reactions primarily involve central 
nervous system and cardio vascular system. The blood level required to produce central 
nervous system toxicity is less than that required to produce circulatory collapse. 
Central Nervous System Toxicity:   
Initial symptom includes feeling of light headedness and dizziness, followed by 
visual and auditory disturbances. Objective signs are excitatory and includes shivering, 
muscle twitching and tremor. Ultimately generalized tonic, clonic seizures occurs.
Cardiovascular System Toxicity:
The  rate  of  depolarization  in  fast  conducting  tissue  of  purkinje  fibres  and 
ventricular muscle is decreased. The rate of recovery of bupivacaine induced block is 
slower than that of lignocaine. Extremely high concentration of the drug causes sinus 
brady cardia and cardiac arrest.
b) Pharmacology of Fentanyl:
Fentanyl is N-1 (1-phenethyl-4, piperidylpropionalide citrate)
It is a synthetic narcotic agonist that is related to phenyl piperidine derivative.
Fentanyl is 75-to-125 times more potent than morphine as an analgesic agent. It 
has got a rapid onset and a shorter duration of action.
Availability:
Ampoules - 2ml containing 100µg
- 10ml containing 50µg/ml
Lollipop - for paedatric use
Patches - Transdermally delivering a dose of 75 to 100µg/hour
Routs of Administration:
Fentanyl is the only opioid available for various forums of administration. 
It can be used by the following routs:
 Intramuscular
 Intravenous
 Neuroxial  –  Spinal,  epidural  administration  for  intra  and  post  operative 
analgesia. 
 Transdermal – applied before the induction of anaesthesia and left in place for 
24 hours. It can reduce the amount of parenteral opioid requirement for post 
operative analgesia.
 Tansmucosal: to decrease the anxiety and to facilitate induction of anaesthesia 
especially in children.
Dosage:
Intramuscular - 1-2µg/kg
Intravenous - 2-20µg/kg – Intravenous with inhaded anaesthetics.
  50-150µg/kg – sole anaesthetic agent
Intrathecal - 0.25 – 0.5µg/kg
Epidural - Bolus dose - 1µg/kg 
  Continuous infustion – 30-300µg/hour
Onset time and duration of action
Routs of administration Onset time (minutes) Duration of action (minutes)
Intramuscular 7-8mts 1-2hour
Intravenous Immediate 0.5-1hour
Epidural 10mts 2-3hours
Pharmacokinetics:
MW - 528
Pka - 8.4
Plasma protein binding - 84%
t1/2 – α - 1-2mts
t1/2 – β - 10-30mts
t1/2 – g - 2-4mts   
Being  a  highly  lipophilic  opioid  the  vascular  uptake  and  rapid  circulation  to 
brainstem is  more  and the rostral  spread  is  of  smaller  magnitude.  These kinetics  of 
Fentanyl  is  in  contradiction  to  morphine  and clinically  produces  rapid  onset  shorter 
duration of action, early but not delayed respiratory depression.
Once the Fentanyl is systemically absorbed, it is rapidly redistributed to inactive 
tissue  sites  such  as  fat  and  skeletal  muscles  with  an  associated  decline  in  plasma 
concentration. The lungs also serve as a large inactive storage sites, with an estimated 
75% of the initial Fentanyl dose undergoing first pass pulmonary uptake. 
Fentanyl  is  extensively  metabolized  by  dealkylation,  hydroxylation  and amide 
hydrolysis to inactive metabolites including nor fentanyl and desporprionyl nor fentanyl 
that are excreted in the bile and urine.
The pharmacokinetics of Fentanyl can be described as three compartment model 
with a distribution time of 1.7 minutes redistribution of 13 minutes and a terminal half 
time of 219 minutes. The volume of distribution is 42ml/kg.
Gastric acidity can ionize Fentanyl and prevents its systemic absorption and once 
the  acidity  is  neutralized  the  systemic  absorption  can  increase  the  plasma  Fentanyl 
concentration. Entero hepatic circulation of Fentanyl can explain the delayed respiratory 
depression seen in some cases.
MODE OF ACTION:
Opioid Receptor:
Opioids act as agonist at stereospecific opioid receptors at presynaptic sites in the 
central  nervous  system (principally  the  brainstem and  spinal  cord)  and  outside  the 
central nervous system in peripheral tissues.
Mu,  Kappa,  Sigma,  Delta  and  Epsilon  are  the  different  opioid  receptors 
distributed in the supraspinal areas (periaqueductal grey mater,  caudate, striatum and 
putamen) and the spinal cord (highest density in the substantia gelatinosa)
Fentanyl acts on the  µ receptor in the supraspinal areas and on kappa and delta 
receptors in the spinal cord producing spinal analgesia.
Intra thecally administrated Fentanyl gets attached to the spinal opioid receptors 
situated densly in the substantia gelatinosa and systemic absorption of the Fentanyl can 
lead to supraspinal receptors binding and its effects.
Investigation suggest  that  different  receptors  are  existing for  different  opioids. 
These receptors are distributed throughout the central nervous system and other parts of 
the brain like paleothalamic pathway, limbic system, medial thalamic nuclei, aqueductal 
grey mater, reticular formation, periventricular areas of medulla, substantia gelatinosa of 
spinal cord, lamina I & II of spinal cord.
Opiate receptors are proteolipids which can bind to both agonists and antagonists. 
CLASSIFICATION OF OPIOID RECEPTORS
‘µ’ Receptor:
Stimulation of  this  receptor  causes supraspinal  analgesia,  euphoria,  respiratory 
depression  and  physical  dependence.  This  receptor  is  sterospecific  and  naloxone 
sensitive.  Endogenous  ligand  for  µ receptor  is  endorphin  and  exogenous  ligand  is 
morphine, the selective antagonist being naloxone.
µ1 receptor:
Stimulation  of  this  receptor  causes  supraspinal  analgesia  and  physical 
dependence.
µ2 receptor:
Stimulation  of  this  receptor  causes  respiratory  depression,  inhibition  of  gastro 
intestinal tract motility and cardiovascular system effects.
K receptor:
Ketocyclozocine  is  the  prototype  agonist.  Stimulation  causes  spinal  analgesia, 
sedation,  miosis,  physical  dependence and inhibition of  ADH secretion.  Endogenous 
ligand is dimorphine and the selective antagonist is naloxone.
‘δ’ receptor:
This  receptor  has  high  affinity  for  adrenocorticotrophic  peptide  harmone. 
Function  is  not  clear  but  it  may  be  responsive  for  modulation  of  activity  of  ‘G’ 
receptors.
It may cause spinal analgesia and respiratory depression. It is not sterospecific and 
is naloxone insensitive.
‘σ’ receptor:
Stimulation  of  this  receptor  cause  dysphonia,  hallucination,  mydriasis  and 
respiratory depression.
‘ε’ receptor: 
This receptor is not well characterized at present and it may be responsible for the 
stress  response  to  pain.  Endogenous  ligand is  p-endorphin  and the  autagonist  being 
naloxone.
Opioid  receptor  in  the  limbic  system  and  hypothalamous  are  related  to  the 
emotional  components  of  pain.  Encephalin  containing  receptors  are  found  in 
Meissener’s  plexus  of  duodenum,  which  probably  affects  gastro  intestinal   motility. 
Opiate receptor are found in large numbers in the area postrema, which contain chemo 
receptor trigger zone, the site where opioids are thought to induce nausea and vomiting.
Mechanism and Site of Action:
Recent studies now point to the dorsal horn of spinal cord is the site of action of 
spinal  opiate  based  upon  ionatophoretic  and  micro  injection  data.  Radio  labeled 
morphine (or) Fentanyl showed a strong focus of activity on the substantia gelatinosa. 
Opiate  receptors  are  located  both  presynaptically  at  the  terminal  of  primary 
sensory  afferents  entering  the  dorsal  horn  and  on  the  dentrites  of  post  synaptic 
membranes.
Presynaptically opiate peptides inhibit the release of substance-P, glutamate and 
other  neurotransmitter  like  acetylcholine  nor  adrenaline,  dopamine  from  sensory 
neurons.  They  also  act  post  synaptically  by  decreasing  the  excitatory  post  synaptic 
potentials induced by persistant afferent stimulation.
Intraoperatively subarachnoid narcotics potentiate the antinociception provided by 
the  local  anaesthetic  agents.  There is  enhancement  of  comfort  and also  the visceral 
manipulation are better tolerated.
Fentanyl also binds to M3 muscarinic receptors in the heart leading to bradycardia 
which can be prevented by giving atropine to the patient.
Fentanyl  also  antagonizes  5-HT  level  in  the  brain,  there  by  potentiating  the 
analgesic activity of other opioids.
PHARMACEODYNAMICS OF FENTANYL:
i) Cardiovascular System:
It produces bradycardia by binding to M3 receptors. It slows AV node conduction 
and prolongs PR interval.
ii) Respiratory System:
It  can  cause  early  respiratory  depression  peak  effect  is  noted  5-15  minute 
following intravenous injection. Very rarely delayed respiratory depression can occur.
iii) Musculo Skeletal System: 
It may cause muscle rigidity, particularly involving the muscles of the chest wall.
Skeletal muscle movements of various groups in the extremities, in the neck and 
in extra-ocular muscles have been reported during induction of anaethesia. This effect is 
related to the dose and speed of injection.
iv) Central Nervous System:
It  produces  euphoria,  sedation  and  miosis.  It  will  not  interfere  with  evoked 
potential monitoring. 
v) Gastro Intestinal Tract:
It causes nausea, vomiting and biliary spasm.  
ADVERSE EFFECTS:
a) Respiratory Depression:
Various  studies  have  showed  that  respiratory  depression  may  occur  after  any 
Opioid irrespective of its routs of administration.
b) Urinary Retension:
It is likely to interact with Opioid receptors located in sacral segments of spinal 
cord. This in turn  promots  inhibition of sacral parasympathetic nervous system outflow 
which causes detrusor muscle relaxation and an increase in maximum bladder capacity 
leading to urinary retention.
c) Pruritus:
Most  common  side  effect  is  pruritus.  The  incidence  is  0-100%.  It  may  be 
generalized (or)  localized to the face,  neck and upper thorax.  The sensation appears 
around (or) just after the development of analgesia by epidural (or) intra thecal Opioids. 
d) Nausea and Vomiting:
Intra operative incidence is 30%. It may be due to the cephalad migration of drug 
and subsequent interaction with Opioid receptors in vascularized area postrema.
e) Hypotension:   
Intra  thecal  pethidine  and  sufentanil  cause  hypotension.  Where  as  intrathecal 
Fentanyl does not cause this effect. The mechanism is not known.
f) Delayed gastric emptying:
This effect is mediated at the spinal level and hence neuroxial opioids are not 
exempt from this effect.
g) Other side effects:
 Chest wall muscle rigidity
 Apnoea
 Bradycardia
 Diaphoresis
 Emesis
 Dizziness
 Blurred vision
Over Dosage and its Treatment:
The  manifestations  of  Fentanyl  over  dosage  are  an  extension  of  its 
pharmacological actions
Effects Treatments
1. Hypoventilation Oxygen therapy assisted (or) controlled ventilation
2. Severe respiratory depression Nalaxone
3. Hypotension Parenteral fluid therapy
4. Pruritus Chlorpheniramine maleate
 
HISTORY AND REVIEW OF LITERATURE
History:
SUB ARACHNOID BLOCK:
In  1885,  J.Leonard  corning  a  New  York  neurologist  first  used  cocaine 
experimentally in dogs. In men the first spinal anaesthesia was conducted by August 
Bier on 16.08.1898 with cocaine 3cc as 0.5% solution.
It was followed by Rudolf matas in America and Tuffier in France.
Bupivacaine:
It was synthesized in Sweden by Ekenstam and his colleagues in 1957 and used 
clinically by L.J.Telivl. Jo in 1963.
Intrathecal Opioids:
Gate control theory of pain (1965) by Melzack and Wall focused the attention on 
importance of dorsal horn of spinal cord in the modulation of pain.
In 1973, Pert (and) Snyder identified the specific opiate receptors in the substantia 
gelatinosa of dorsal horn of spinal cord.
In 1976, spinal effects of intra thecal opiates in animals were demonstrated by 
Yaksh and Rudy.      
In 1977, Wang, Naurs and Thomas studied the effect of intra thecal morphine in 
men  with  intractable  pain  of  lowerlimb  due  to  malignancies  invading  lumbosacral 
plexus. 
In  1980,  Davier  et  al,  identified  that  respiratory  depression  with  intratheeal 
morphine was reversed with systemic naloxone without reversing analgesia.
In  1981,  Yaksh  and  Rudy  described  the  action  of  intrathecal  pethidine  and 
morphine in primates by iontophoretic administration of the drugs in to the substantia 
gelatinosa.  They  found  out  high  level  of  opiates  binding  in  substantia  gelatinosa 
indicating  the  presynaptic  action  of  opiate.  Spinal  opiates  also  seemed  to  cause 
significant elevation of noeicpetive threshold.    
In 1984, Huang HJ, Ishimain T, Yambe studied the use of intrathecal morphine 
for post operative pain relief.
In 1988, Inagaki. Y, Takeyama E studied the efficacy of post operative pain relief 
after the use of intrathecal Buprenorphine with local anaesthetic agent and found it to 
prolong the post operative analgesia.
FENTANYL AND INTRATHECAL ANAESTHESIA:
The  increased  availability  of  lipid  soluble  opioids  with  shorter  latency  and 
demonstration of synergistic effect of opioids when combined with local anaesthetics 
have led to the widespread use of neuroxial opioids. The effect of lipophilic agents are 
better when administered at the level at which analgesia is required. Commonly used 
opioids are meperidine, Fentanyl and sufentanil.
Mok  et  al  1984,  Intra  thecal  injection  of  Fentanyl,  sufentanil,  alfentanil  and 
nalbuphine have been reported for post operative analgesia with promising results.
Wang,  Chen  MB  et  al  1993,  This  study  examined  the  effect  of  Bupivacaine 
administered intrathecally on sympathetic efferent and ‘A’ delta and ‘C’ fibre mediated 
afferent pathways in dogs and the interactions with intrathecal fentanyl.  The  results 
showed that  intra  thecal  bupivacaine  has  no  selectivity  for  the afferent  and efferent 
pathways  and  intratheeal  Fentanyl  acts  synergistically  to  enhance  the  effect  of 
bupivacaine on the afferent pathway without a measurable effect on sympathetic out 
flow.    
Singh, Harbheo, Yang et al 1995, They studied the effect of intrathecal Fentanyl 
on the onset and duration of hyperbaric bupivacaine induced spinal block in adult male 
patients  undergoing  genito  urinary  surgery.  They  concluded  that  Fentanyl  25µg, 
prolongs the duration of bupivacaine induced sensory block by 28% and increased the 
post operative analgesia.
Hunt et al reported that addition of Fentanyl 6.25µg to the hyperbaric bupivacaine 
reduced  the  intra  operative  Opioid  requirement  in  patients  undergoing  caesarean 
delivery under sub arachnoid block.
Belzarena et al demonstrated that low dose Fentanyl 0.25µg/kg with bupivacaine 
0.5% provided excellent surgical anaesthesia with few side effects. An increased dose of 
Fentanyl to 0.5µg/kg was associated with an increased incidence of adverse effects in 
patients undergoing caesarean delivery.
Ce-Ben David et al 1997, By exploring the synergism between intrathecal opioids 
and local  anaesthetics,  it  may  be  possible  to  augment  the  spinal  anesthesia  without 
prolonging the recovery. Based on this fact they have done the study on 50 patients 
undergoing ambulatory surgical arthroscopy. Implications:  Small dose bupivacaine is 
inadequate for this procedure but the addition of Fentanyl makes it reliable.
Roussel JR et al 1999, they have concluded a study on the effects of intrathecal 
Fentanyl on duration of bupivacaine spinal blockade for out patient knee arthroscopy 
and concluded that Fentanyl does not enhance the onset and duration of sensory (or) 
motor  block  produced  by  intratecal  bupivacaine.  Fentanyl  however  prolong  post 
operative analgesia and increases the risk of pruritus.
Ben  David  B,  Frankel  R  et  al  2000,  They  studied  the  effect  of  mini  dose 
bupivacaine  fentanyl spinal anaesthesia for surgical repair of hip fracture in the aged. 
The synergism between intrathecal opioids and local anaesthesia may make it possible to 
achieve reliable spinal anaesthesia with minimal hypotension using a small dose of local 
anaesthetic. 20 patients of more than 70 years of age for surgical repair of hip were 
divided in to 10 patient of group each. 
Group A - Received bupivacaine 4mg and Fentanyl 20µg        
Group B - Received 10mg of bupivacaine alone.
They  concluded  that  the  mini  dose  combination  caused  dramatically  less 
hypotension  than  10mg bupivacaine  and  nearly  eliminated  the  need  for  vasopressor 
support of blood pressure.
Pramod  Patra,  Mukul  Chandra  Kapoor,  Trevor  Gordon  Michael  Nair.  They 
studied the effect of low dose bupivacaine with Fentanyl for elderly patients undergoing 
endoscopic  urological  procedure.  They  concluded  that  the  addition  of  Fentanyl  to 
bupivacaine  provide adequate  surgical  anaesthesia  with  an  ideal  peak sensory  block 
height and significantly reduces the duration of both sensory and motor blockade, with 
no significant adverse effects apart from pruritus, facilitating early discharge of patients. 
The technique was found suitable for day care endoscopic urologic procedure.
Ben David B, Levin H, Solomon E, et al, studied spinal anaesthesia in ambulatory 
surgery.  The  effect  of  saline  dilution  was  studied.  They  concluded  that  the  most 
important determinant of both successful surgical anaesthesia and time until recovery is 
the dose of local anaesthetic drug.
MATERIALS AND METHODS
After  getting  the  approval  from  the  ethical  committee  of  the  department  of 
anaesthsiology, Govt. Rajaji Hospital attached to Madurai Medical College, Madurai. 
The study was conducted in 75 patients aged 50-75years undergoing elective endoscopic 
urologic  procedures.  After  getting  consent  and  explaining  the  procedure  details  the 
anaesthetic technique was performed.
EXCLUSION CRITERIA:
 Patient refusal
 ASA III & IV patients
 Post spinal surgeries
 Spinal deformity
 H/o drug allergy
Preoperative preparation:
After routine preoperative assessment as for all elective surgery patients they were 
premedicated with injection Midazolam 2mg Im 30-45 minutes before surgery.
Patients were randomly divided into three groups.
Group B - Received Inj. 0.5% Bupivacaine 1.5cc
Group FI - Received Inj. 0.5% Bupivacaine 1cc +
Inj. Fentanyl 0.5cc = 1.5cc
Group FII - Received Inj. Bupivacaine 0.8cc+
Inj. Fentanyl 0.5cc+
Sterile water 0.2cc =1.5cc
   
PROCEDURE DETAILS:
On preoperative  visit  the  patients  were  explained  about  the  procedure  details. 
Then preoperative baseline parameters like pulse rate, blood pressure, respiratory rate 
were recorded.  Iv line started with 18 gauge intra  venous cannula  and infused with 
crystalloids.
Following emergency drugs and equipments were kept ready before anaesthesia 
intervention.
 Boyles machine with oxygen cylinder
 Oxygen source
 Laryngoscope with various blades
 Airway in all sizes
 Suction apparatus 
 Emergency drugs like ephedrine, dopamine, atropine and adrenaline
 Naloxone
Patients were put in right lateral position and with strict aseptic precaution lumbar 
puncture was done with quinke standard 23 guage spinal needle.
After ensuing free flow of CSF drug was injected as per the group assigned.
The assigned amount of Fentanyl and strile water were taken in sterile tuberculine 
syringe. 
After injection patient were put up in supine position. After attaining adequate 
peak level  of  sensory block the patient  was put  up in lithotomy position.  If  needed 
oxygen was given through ventimask. 
THE FOLLOWING PARAMETERS WERE RECORDED
1. Time of highest level of sensory block achieved by pin prick and temperature.
2. Degree of motor blockade assessed by using bromage scale.
3. Pulse rate, Blood pressure, respiratory rate, spo2 were monitored every 2 minutes 
for 10 minutes and every 5 minutes till the end of surgery.
4. Any discomfort like nausea, vomiting, pruritus and shivering.
5. Hypotension is said to have occurred if there was 30% fall from base line and was 
treated with 100% O2, Intravenous fluid bolus and Inj. Ephedrine in incremental 
doses.
6. Bradycardia – if present was treated with Inj. Atropine.
7. Sedation score
8. Incomplete sensory block
9. Post operative observation:
a. Duration of procedure
b. Level at the end of surgery
c. Duration of post operative analgesia
d. Two  segment  regression  time  (i.e.  the  time  taken  to  decrease  from 
maximum sensory level by two segments from initial level is noted)
SEDATION SCORE:
Brain and Ready sedation score was employed
0 - Fully awake 
1 - Drowsy
2 - Drowsy but arousable on touch (or) call
3 - Drowsy but arousable on deep stimuli
4 - Somnolent
In the post operative period total duration of analgesia was taken as that period 
from time of subarachnoid block till patient requirement of analgesic medicine.
Pain was evaluated using VISUAL ANALOG SCALE.
0-1 - Excellent   
2-4 - Good
5-6 - Fair
7-8 - Poor
9-10 - No relief
Pain score >6 – supplementary analgesia given.
MOTOR BLOCK WAS ASSESSED BY BROMAGE SCALE
0 - Full flexion of knees, feet, able to lift the extended leg
1 - Unable to lift the extended leg. Just able to flex the knees and full 
  flexion of feet possible
2 - Unable to flex the knees but flexion of feet possible.
3 - Unable to move the leg (or) feet
also  in  the  post  operative  period  all  patients  were  followed  up  for  any 
complications like post operative nausea, vomiting, pruritus, hypotension and respiratory 
depression.
Statistical significance was brought out by ANOVA table.
RESULTS
A. PROFILE OF CASES STUDIED
Table 1 : Age distribution
Age group
Cases in
Group B Group F1 Group F11
No. % No. % No. %
Less than 50 years - - - - - -
50– 54 years 5 20 7 28 5 20
55 – 59 years 8 32 1 4 2 8
60 – 64 years 4 16 10 40 7 28
65 – 69 years 5 20 5 20 6 24
70 years & above 3 12 2 8 5 20
Total 25 100 25 100 25 100
Mean
S.D.
60.2
7.0
60.2
6.6
62.4
8.2
‘p’ 0.5025
Not significant
Table 2 : Sex distribution
Sex
Cases in
Group B Group F1 Group F11
No. % No. % No. %
Males 23 92 24 96 22 88
Females 2 8 1 4 3 12
Table 3 : History of illness
Illness
Cases in
Group B Group F1 Group F11
No. % No. % No. %
D.M. 5 20 1 4 4 16
H.T. 3 12 5 20 3 12
I.H.D. 1 4 1 4 - -
COPD - - 2 8 1 4
Others 7 28 3 12 2 8
Table 4 : Baseline data
Parameter
Cases in
Group B Group F1 Group F11
No. % No. % No. % ‘p’
Pulse Rate 87.1 7.3 82.1 6 81.7 7.4 0.0681
Not 
Significant
Respiratory 
Rate
14.52 3.23 14.12 2.09 14.12 2.24 0.9714
Not 
Significant
Systolic B.P. 120.4 14.85 123.2 11.08 124.4 8.7 0.2972
Not 
Significant
Diastolic B.P. 77.2 7.4 79.2 7 78 7.1 0.4766
Not 
Significant
B. INTRA OPERATIVE OBSERVATION
Table 4 : Maximum Sensory Level
Maximum 
Sensory Level
Cases in
Group B Group F1 Group F11
No. % No. % No. %
T6 1 4 - - - -
T7 2 8 - - - -
T8 1 4 5 20 2 8
T9 9 36 10 40 4 16
T10 10 40 8 32 19 76
T11 2 8 2 8 - -
Total 25 100 25 100 25 100
Mean
S.D.
9.24
1.2
9.28
0.89
9.68
0.63
‘p’ 0.1243
Not Significant
Table 5 : Time of Maximum Sensory Level
Maximum 
Sensory Level
Cases in
Group B Group F1 Group F11
Range 5-9 5-8 5-7
Mean 7.0 6.0 6.16
S.D. 1.15 0.91 0.8
‘p’ 0.0021
Significant
Table 6 : Grading of Motor Block
Motor Block 
Grade
Cases in
Group B Group F1 Group F11
No. % No. % No. %
1 - - - - 1 4
2 1 4 2 8 9 36
3 13 52 18 72 14 56
4 11 44 5 20 1 4
Total 25 100 25 100 25 100
Mean
S.D.
2.4
0.58
2.12
0.53
1.6
0.65
‘p’ 0.0001
Significant
B. INTRA OPERATIVE HAEMODYNAMIC CHANGES
Table 7 : Changes in Pulse Rate
Pulse Rate
Cases in
Group B Group F1 Group F11
No. % No. % No. %
‘p’
Base line 87.1 7.3 82.1 6 81.7 7.4 0.0681 
Not significant
At 5 minutes 88.8 7.2 83.1 7.6 86.2 8.8 0.0281
Significant
At 10 minutes 89.3 7.1 85 5.5 85.5 5.5 0.0081
Significant
At 15 minutes 89.3 6.3 84.7 5.3 85 4.8 0.0019
Significant
Changes at
5 minutes 1.72 11.71 0.96 7.93 4.48 8.54 0.5674
Not significant
10 minutes 2.16 12.12 2.92 6.53 3.8 7.75 0.9459
Not significant
15 minutes 2.16 11.23 2.6 6.71 3.24 7.77 0.9525
Not significant
% of change at
5 minutes 2.97 14.52 1.49 9.97 5.92 10.73 0.4771
Not significant
10 minutes 3.53 14.74 3.95 8.62 5.33 10.33 0.9385
Not significant
15 minutes 3.47 13.87 3.59 8.88 4.69 10.43 0.9638
Not significant
Table 8 : Changes in Systolic B.P.
Systolic B.P.
Cases in
Group B Group F1 Group F11
No. % No. % No. %
‘p’
Base line 120.4 14.85 123.2 11.08 124.4 8.7 0.2972
Not 
Significant
At 5 minutes 102.64 17.77 117.2 12.08 117.6 8.79 0.0012 
Significant
At 10 minutes 110.3 10.69 116.4 9.95 115.6 11.58 0.0961
Not 
Significant
At 15 minutes 111.2 10.92 116.4 9.95 118.4 9.43 0.0501
Not 
Significant
Changes at
5 minutes -17.76 14.45 -6 10 -6.8 8.52 0.0006
Significant
10 minutes -10.08 10.96 -6.8 7.48 -8.8 10.13 0.4863
Not 
Significant
15 minutes -9.2 8.62 -6.8 9.45 -6 7.07 0.3769
Not 
Significant
% of change at
5 minutes -14.62 11.63 -4.65 7.94 -5.28 6.63 0.0002
Significant
10 minutes -7.84 8.59 -5.35 6.08 -7.04 8.11 0.2302
Not 
Significant
15 minutes -7.19 6.63 -5.2 7.46 -4.7 5.57 0.1931
Not 
Significant
Table 9 : Changes in Respiratory Rate
Respiratory 
Rate
Cases in
Group B Group F1 Group F11
No. % No. % No. % ‘p’
Base line 14.52 3.23 14.12 2.09 14.12 2.24 0.9714
Not 
Significant
Intra 
operative
14.08 2.48 13.4 1.68 14.56 2.63 0.2382
Not 
Significant
Change -0.44 2 -0.72 2.01 0.44 1.64 0.1167
Not 
Significant
% of change -1.44 13.27 -3.95 13.33 3.44 11.23 0.1044
Not 
Significant
Table 10 : Complications
Complications
Cases in
Group B Group F1 Group F11
No. % No. % No. %
Incomplete 
Sensory Block
- - - - 2 8
Nausea / 
Vomiting
- - - - - -
Pruritus - - 6 24 4 16
Any 
discomfort
- - - - - -
Incomplete sensory block was present in 8% of patients in Group FII
Table 11 : Sedation Score
Sedation 
Score
Cases in
Group B Group F1 Group F11
No. % No. % No. %
0 22 88 2 8 3 12
1 3 12 16 64 16 64
2 - - 5 20 6 24
3 - - 2 8 - -
Total 25 100 25 100 25 100
Mean
S.D.
0.12
0.33
1.28
0.74
1.12
0.6
‘p’ 0.0001
Significant
Sedation Score was more in Fentanyl group 
Table 12: Duration of Procedure
Duration of Procedure 
in minutes
Group B Group F1 Group F11
Range 20 – 60 20 – 60 25 – 75
Mean 32 39.4 54.2
S.D. 10.2 10.3 12.7
‘p’ 0.0001
Significant
Table 13: Two seg. regression time 
Two seg. 
regression time in 
minutes
Group B Group F1 Group F11
Range 78 – 95 77 – 117 69 – 101
Mean 85.8 95.7 82.5
S.D. 5.74 9.13 8.85
‘p’ 0.0001
Significant
Two  segment  regression  time  was  significantly  prolonged  in  group-FI  (‘P’ 
0.0001) 
Table 14: Duration of post operative analgesia
Duration of post 
operative analgesia in 
minutes
Group B Group F1 Group F11
Range 85 – 108 92– 127 75 – 105
Mean 95.4 105.8 90.4
S.D. 4.4 9.3 7.8
‘p’ 0.0001
Significant
Duration of post operative analgesia was significantly prolonged in Group FI
Statistical Tools (To be included at the end of Materials and Methods)
The  information  collected  regarding all  the  selected  cases  were  recorded in  a 
Master Chart. Data analysis was done with the help of computer using Epidemiological 
Information Package (EPI 2002).
Using this software, range, frequencies, percentages, means, standard deviations, 
chi square and 'p' values were calculated. Kruskul Wallis chi-square test was used to test 
the significance of difference between quantitative variables. A 'p' value less than 0.05 is 
taken to denote significant relationship.
OBSERVATION AND RESULTS
In this randomized single  blinded study conducted in 75 patients,  the  subjects 
were allocated in to three groups.
Group B - Received Inj. 0.5% Bupivacaine 1.5cc 
Group FI - Received Inj. 0.5% Bupivacaine 1cc+ 25µg of Inj. 
  Fentanyl 
Group FII - Received  Inj.0.5% Bupivacaine 0.8cc + Inj. 
  Fentanyl 25µg + Sterile water 0.2cc
DEMOGRAPHIC DATA:
All 3 groups were comparable in age, sex, duration and nature of surgery. 
HIGHEST DERMATOMAL LEVEL:
Maximum level achieved
Group B - T9
Group FI - T9
Group FII - T10
 
TIME OF MAXIMUM SENSORY LEVEL:
Group B - 7mts with SD of 1.15
Group FI - 6mts with SD of 0.91
Group FII - 6.16mts with SD of 0.8
GRADING OF MOTOR BLOCK:
Group B - 44% of patients had grade 3
                     52% of patients had grade 2
                               4% of patients had grade 1
         Group F1   -20% of patients had grade 3
                             72% of patients had grade 2
                             8% of patients had grade 1
         Group F11-4% of patients had grade 3
                            56% of patients had grade 2
                            36% of patients had grade 1
                            4% of patients had grade 0   
HAEMODYNAMIC VARIABLES:
With regard to blood pressure more than 30%free from the base line value was 
considered hypotension.
In Group B - 25% of patients had significant hypotension
In Group FI - There was no significant fall in blood pressure  
In Group FII - There was no significant fall in blood pressure 
Considering three groups plain bupivacaine group had significant haemodynamic 
impairment when compared to Fentanyl group, and they required intravenous fluids, Inj. 
Ephedrine and oxygen supplementation. Of the 2 fentanyl groups none had significant 
changes in haemodynamic parameters.
INCOMPLETE SENSORY BLOCK:
In group FII 8% of patients had incomplete sensory block and they felt discomfort 
during the surgical procedure. They were supplemented with Inj. Propofol 1mg/kg + Inj. 
Fentanyl 1µg/kg intravenously and oxygen.
SEDATION:
Intra operative sedation was excellent in group FI & Group FII
In Group B - 88% had sedation score of 0      
  12% had sedation score of 1
In Group FI - 8% had sedation score of 0
  64% had sedation score of 1
  20% had sedation score of 2
  8% had sedation score of 3
In Group FII - 12% had sedation score of 0
  64% had sedation score of 1
  24% had sedation score of 2
TWO SEGMENT REGRESSION TIME:
Duration of analgesia as measured by two segment regression time in Group 
B was 85.8mts with SD of 5.74
Group FI was 95.7mts with SD of 9.13
Group FII was 82.5mts with SD of 8.85   
TOTAL DURATION OF ANALGESIA:
Total duration of pain free interval in
Group B was 95.4mts with SD of 4.4
Group FI was 105.8mts with SD of 9.3
Group FII was 90.4mts with SD of 7.8
COMPLICATIONS:
Nausea and vomiting was not found in all groups.
Pruritus developed in
Group FI - 24% of patients 
Group FII - 16% of patients
All responded to Inj. Chlorpheniramine maleate Im.
DISCUSSION
The  pain  we  perceive  after  a  burn,  bite  (or)  pinch  is  readily  identifiable  but 
difficult to define because it is differently perceived at different threshold.
Pain is defined as psychical adjunct of protective reflex – by sherington in 1906.
The  international  association  of  society  for  pain  (IASP)  defined  it  as  “An 
unpleasant sensory and emotional experience associated with actual (or) potential tissue 
damage (or) described in terms of such damage”
The use of opioids to control pain exists even in ancient history and opioids are 
still the primary analgesic chosen for sever pain.
Advantage of intrathecal administration of narcotics are
 Easier administration at the time of induction of anaesthesia.
 Very  small  dose  and  there  fore  reduced  blood  concentration  of  Opioid  and 
reduced risk of complications. 
Because  most  of  the  cystoscopic  urological  procedures  are  performed   under 
subarachnoid  block the  utility  and safety  of  intrathecal  opioids  for  pain  relief  is  of 
important clinical concern. 
This  study  combined   Fentanyl  with  low  dose  of  local  anaesthetic  aimed  to 
delineate the safe limit of local anesthetic that could be added to Fentanyl for elderly 
patients under going endoscopic urological procedures without much untoward effect. 
INTRA OPERATIVE COMFORT:
Addition  of  Opioid  aids  in  relieving  the  discomfort  that  could  be  casued  by 
visceral handling.
  -8% of patients in group FII felt discomfort during the surgery and they needed 
intravenous analgesic supplement otherwise all patients were comfortable.
- All patients in fentanyl group were comfortable in lithotomy position though the 
motor block was low
HAEMODYNAMICS:
The haemodynamics were stable in Fentanyl group than plain bupivacaine group 
(P 0.0012) 28% of group B had hypotension.
This observation is similar to A.Kararmaz et al.
SEDATION:
In Fentanyl group most of the patients were sedated well with sedation score of 
more than 1 (P 0.00013) than plain bupivacaine group.
PRURITUS:
The incidence of pruritus in group FI is 24% and in group FII is 16%. Nausea and 
vomiting was not found in any of the three groups.
TWO SEGMENT REGRESSION TIME:
Two segment regression time was significantly prolonged in Group F1 “P”0.0001.
The above observation is similar to one observed by Prof.Naveen Malhotra et al, 
Ben David et al.
DURATION OF POST OPERATIVE ANALGESIA:
The duration of post operative analgesia was significantly prolonged in Group F1 
“P” 0.0001.
       
RESPIRATORY DEPRESSION:
Previous studies by Bromage et al in 1981, Lan et al 1983 Showed that Fentanyl 
upto 25µg did not cause delayed respiratory depression.
They  concluded  that  respiratory  depression  effect  is  dose  dependant  and it  is 
unlikely to occur at a dose below 25µg.
In this study the respiratory rate remained unchanged with the base line.
This study delineates the optimal dose of Bupivacaine and Fentanyl without much 
morbidity in hospital with moderate post operative care. 
CONCLUSION
This study is conducted in patients aged 50-75 years.  Spinal  Bupivacaine was 
used in variable doses with Fentanyl 25µg to find out the minimum effective dose of 
bupivacaine with Fentanyl 25µg in elderly patients undergoing endoscopic urological 
procedures. 
       In group B 28% of the patients had significant hypotension who needed bolus 
intravenous fluids and vasopressors.
      In group F1 the haemodynamics were stable with significant prolongation of  post 
operative analgesia than other groups.
      In  group  F11  8% of  the  patients  had  intra  operative  discomfort  who  needed 
supplemental intravenous analgesia.
      From this study it was concluded that addition of Fentanyl 25µg to 5mg of 0.5% 
Bupivacaine provides reliable and satisfactory surgical anaesthesia with an ideal peak 
sensory block height, stable haemodynamic  status and without any significant adverse 
effect in elderly patients undergoing endoscopic urologic procedures.
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PROFORMA
Name:                                Age:              Sex:                      IP No:
Ht:                Wt:                   ASA:               Duty anaesthesiologist:
Pre operative status- PR:              BP:           RR:           CVS:              RS:
Blood investigations:        Hb%:                RBS:         Urea:      Creatinine:
Blood grouping:                        H/o drug allergy:
Pre medication: inj. Midazolam 2mg Im 45 minutes before surgery.
                                              PARAMETERS OBSERVED
1.Level of sensory block achieved and time:
2.Degree of motor block:
3.PR:                    BP:                    RR:                            Spo2:
4.Any discomfort:  Nausea:              Vomiting:                    Pruritus:
5.Level at the end of  surgery:
6.Hypotension- >30% fall:                                                         Yes/No
7.Bradycardia:   <60/mt:                                                            Yes/No
8.Incomplete sensory block:                                                      Yes/No
9.Pruritus:                                                                                   Yes/No
10.PONV:                                                                                   Yes/No
11.Shivering:                                                                              Yes/No
12.Sedation score:
13.Duration of procedure:
14.Level at the end of surgery:
15.Two segment regression time:
16.Duration of post operative analgesia:
  SEDATION SCORE:
                    0 – Fully awake
1- Drowsy
2- Drowsy but arousable on touch (or) call
3- Drowsy but arousable on deep stimuli 
4- Somnolent
   VAS-        0 hr
                    1 hr
                    2 hrs
                    3 hrs
                    4 hrs
Visual analog scale.        0 – 1    Excellent
                                           2 -  4     Good
                                           5 – 6      Fair
                                           7  - 8      Poor
                                           9 – 10    No relief
Pain score  >6- Supplementory analgesia given.
                 
Motor block – assessed by Bromage scale:
 0 – Full flexion of knees, feet, able to lift the extended leg.
1- Unable to lift the extended leg. Just able to flex the knees and full flexion of feet 
possible.
2-  Unable to flex the knees but flexion of feet possible.
3-  Unable to move the  leg( or) feet.         
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1 B 50 M 42392 No Yes No No No 65 23 150 100 7 7
2 B 60 M 44293 Yes No No No No 96 22 120 80 8 5
3 B 69 M 47256 No No No No No 96 20 120 80 6 5
4 B 58 M 50429 No No No No No 86 14 130 80 7 9
5 B 55 M 47471 No No No No No 78 14 120 80 10 8
6 B 55 M 52156 No No No No No 95 14 120 70 11 7
7 B 60 M 57144 No No No No No 90 18 110 80 9 9
8 B 70 M 53116 Yes No No No No 98 18 120 70 9 7
9 B 51 M 52672 No No No No Yes 82 12 130 80 10 7
10 B 65 M 50740 Yes No No No Yes 90 12 110 80 9 7
11 B 58 M 53742 No No Yes No No 80 12 120 70 10 7
12 B 59 M 51132 No No No No Yes 92 16 150 80 10 7
13 B 58 M 42191 No No No No Yes 90 12 110 70 9 5
14 B 57 M 51463 No No No No No 90 12 110 70 10 8
15 B 75 M 50938 Yes No No No No 82 12 100 70 11 7
16 B 73 M 53728 No No No No No 80 14 130 80 10 5
17 B 52 M 56148 No No No No No 88 14 110 80 9 8
18 B 60 M 55404 No No No No No 82 14 130 80 10 6
19 B 65 M 46541 No No No No Yes 90 14 100 80 9 8
20 B 56 F 59241 No Yes No No No 78 12 120 70 10 8
21 B 51 F 62916 No No No No No 90 14 100 70 9 7
22 B 54 M 61645 No No No No No 90 12 120 70 10 7
23 B 65 M 62419 Yes Yes No No Yes 90 12 150 90 9 6
24 B 60 M 69450 No No No No No 90 14 130 80 10 8
25 B 69 M 63988 No No No No Yes 90 12 100 70 9 7
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1 F I 54 F 44272 No Yes No No No 70 20 140 90 8 6
2 F I 62 M 49343 No No No No No 82 16 110 80 9 7
3 F I 60 M 89216 No Yes No No No 76 14 130 80 8 5
4 F I 62 M 53577 No Yes Yes No No 92 18 130 80 9 5
5 F I 69 M 57965 No No No No Yes 86 16 140 90 10 5
6 F I 70 M 22240 No No No No No 80 14 110 70 9 5
7 F I 60 M 23379 No No No No No 84 14 120 80 9 6
8 F I 57 M 48019 No No No No No 76 12 130 80 10 8
9 F I 76 M 55534 No No No No No 80 12 120 70 9 6
10 F I 60 M 56158 Yes No No No No 90 12 130 80 8 6
11 F I 60 M 56149 No No No No Yes 80 12 110 70 11 5
12 F I 53 M 59391 No No No Yes No 90 12 120 80 11 6
13 F I 62 M 42623 No Yes No No No 78 14 130 80 9 6
14 F I 65 M 40164 No No No No No 86 12 110 70 10 7
15 F I 66 M 40223 No No No No No 80 14 120 70 9 6
16 F I 52 M 28882 No No No No No 90 14 110 80 9 5
17 F I 50 M 28259 No No No No No 68 14 120 70 10 7
18 F I 60 M 38639 No No No No No 82 14 100 70 9 6
19 F I 50 M 65288 No Yes No No No 87 18 140 80 9 5
20 F I 60 M 64647 No No No No No 82 14 120 80 10 5
21 F I 65 M 62892 No No No Yes No 86 13 140 90 8 7
22 F I 60 M 55454 No No No No No 80 14 130 80 10 7
23 F I 52 M 66488 No No No No Yes 86 12 120 90 10 5
24 F I 53 M 66469 No No No No No 78 14 120 80 8 7
25 F I 66 M 68954 No No No No No 84 14 130 90 10 7
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1 F II 60 M 486841 No No No No No 78 16 150 100 10 7
2 F II 75 M 5820 No No No No No 82 16 130 80 10 5
3 F II 54 M 6645 No No No No No 76 12 100 80 10 6
4 F II 50 M 12686 No No No No No 88 13 120 80 10 7
5 F II 75 M 1446 No No No No No 70 12 130 80 10 6
6 F II 65 M 7482 Yes No No No No 80 12 120 70 9 6
7 F II 55 M 4620 No No No Yes No 76 12 120 70 10 5
8 F II 65 M 10775 No No No No No 90 14 120 70 10 5
9 F II 50 F 1007 No No No No No 80 12 120 70 9 7
10 F II 59 F 4307 No No No No No 90 12 120 70 10 6
11 F II 60 M 12692 No No No No No 70 18 120 70 8 7
12 F II 60 M 2430 Yes No No No No 82 18 130 80 10 7
13 F II 60 F 15062 No No No No Yes 90 14 130 80 10 6
14 F II 79 M 20134 No Yes No No No 80 14 130 90 10 5
15 F II 74 M 28837 Yes Yes No No No 92 18 120 80 8 5
16 F II 65 M 20506 No No No No No 76 14 120 80 10 6
17 F II 65 M 258604 No No No No No 80 16 130 80 10 5
18 F II 60 M 21651 No No No No No 70 12 120 70 10 7
19 F II 50 M 28236 No No No No No 86 12 130 80 10 7
20 F II 69 M 25294 No No No No No 86 12 120 80 10 6
21 F II 62 M 28884 No No No No No 70 14 130 80 9 7
22 F II 65 M 47407 No Yes No No No 88 16 120 80 10 7
23 F II 62 M 48405 Yes No No No No 93 18 130 80 10 6
24 F II 51 M 49091 No No No No No 90 14 120 70 9 7
25 F II 70 M 43123 No No No No Yes 80 12 130 80 10 6
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1 B 42392 96 100 94 120 94 130 No 22 No No 0 No 20
2 B 44293 74 120 70 120 72 120 No 18 No No 1 No 35
3 B 47256 74 90 72 100 74 100 No 18 No No 0 No 25
4 B 50429 90 100 90 110 92 110 No 12 No No 0 No 25
5 B 47471 80 120 82 120 82 120 No 12 No No 0 No 25
6 B 52156 98 110 96 110 96 110 No 12 No No 1 No 20
7 B 57144 100 130 90 130 90 120 No 14 No No 0 No 30
8 B 53116 80 110 80 110 82 110 No 14 No No 1 No 20
9 B 52672 90 120 92 120 92 120 No 14 No No 0 No 35
10 B 50740 92 80 94 100 94 100 No 12 No No 0 No 50
11 B 53742 100 110 96 110 96 120 No 12 No No 0 No 45
12 B 51132 94 130 92 130 92 130 No 18 No No 0 No 30
13 B 42191 86 80 94 100 90 100 No 14 No No 0 No 35
14 B 51463 96 90 90 100 90 110 No 12 No No 0 No 25
15 B 50938 90 90 100 100 90 100 No 14 No No 0 No 45
16 B 53728 90 90 92 98 84 110 No 14 No No 0 No 40
17 B 56148 90 80 96 100 96 100 No 14 No No 0 No 20
18 B 55404 86 100 90 110 90 110 No 14 No No 0 No 25
19 B 46541 80 80 82 100 86 100 No 12 No No 0 No 40
20 B 59241 88 100 90 110 96 110 No 14 No No 0 No 30
21 B 62916 92 80 90 100 90 100 No 14 No No 0 No 25
22 B 61645 84 110 90 110 90 110 No 14 No No 0 No 30
23 B 62419 94 140 90 130 90 130 No 14 No No 0 No 60
24 B 69450 91 116 90 120 94 120 No 12 No No 0 No 30
25 B 63988 86 90 90 100 90 90 No 12 No No 0 No 35
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1 F I 44272 100 130 84 110 86 110 No 16 No No 2 No 40 117
2 F I 49343 78 110 80 110 80 110 No 18 No No 1 No 40 103
3 F I 89216 80 100 84 110 80 110 No 12 No No 1 No 35 115
4 F I 53577 86 120 90 120 90 120 No 17 No No 2 No 25
5 F I 57965 92 140 90 120 90 130 No 14 No No 2 No 45
6 F I 22240 90 100 92 100 90 100 No 14 No No 1 No 40
7 F I 23379 86 120 90 110 90 110 No 12 No No 1 No 45
8 F I 48019 84 120 90 120 86 120 No 12 No Yes 1 No 40
9 F I 55534 70 110 80 110 80 120 No 12 No Yes 2 No 45 101
10 F I 56158 96 120 90 120 90 110 No 12 No Yes 3 No 50 107
11 F I 56149 90 100 92 100 92 100 No 14 No Yes 2 No 40
12 F I 59391 90 130 92 120 92 130 No 14 No No 1 No 40
13 F I 42623 86 120 84 120 86 110 No 14 No No 1 No 60
14 F I 40164 76 110 80 110 80 110 No 14 No No 1 No 50
15 F I 40223 86 110 80 110 80 120 No 12 No No 1 No 30
16 F I 28882 92 110 90 110 90 110 No 14 No No 1 No 25 103
17 F I 28259 80 110 84 120 84 120 No 12 No Yes 1 No 20
18 F I 38639 86 110 84 110 86 110 No 14 No No 1 No 25
19 F I 65288 88 130 90 130 80 120 No 12 No No 3 No 60
20 F I 64647 83 110 84 110 86 110 No 12 No Yes 1 No 40
21 F I 62892 70 120 80 130 80 130 No 14 No No 1 No 30
22 F I 55454 86 120 84 130 84 130 No 12 No No 0 No 40
23 F I 66488 80 120 84 110 86 110 No 14 No No 0 No 30
24 F I 66469 64 110 70 110 70 110 No 12 No No 1 No 40
25 F I 68954 78 150 80 140 80 140 No 12 No No 1 No 50
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1 F II 486841 74 130 78 130 78 130 No 20 No No 1 No 70 101
2 F II 5820 84 120 84 120 86 120 No 14 No No 0 No 40
3 F II 6645 84 100 86 100 86 100 No 12 No No 1 No 50
4 F II 12686 90 120 92 120 92 120 No 14 No Yes 1 No 60
5 F II 1446 76 120 78 120 76 130 No 12 No No 2 No 60
6 F II 7482 86 110 88 110 86 110 No 12 No No 1 No 55
7 F II 4620 80 120 82 110 82 110 No 12 No No 2 No 60
8 F II 10775 80 120 84 100 80 100 No 14 No No 1 No 65
9 F II 1007 80 120 86 120 86 120 No 14 No No 1 No 40
10 F II 4307 90 120 92 120 92 120 No 14 No No 1 No 25
11 F II 12692 88 120 90 100 90 110 Yes 16 No No 0 No 60
12 F II 2430 84 120 80 140 80 130 No 18 No Yes 0 No 70
13 F II 15062 100 140 90 130 90 130 No 12 No No 1 No 60
14 F II 20134 86 120 80 120 80 120 No 14 No No 2 No 65
15 F II 28837 96 100 90 100 90 110 No 20 No No 2 No 60
16 F II 20506 86 110 84 110 84 110 No 12 No No 1 No 60
17 F II 258604 82 120 82 120 80 120 No 14 No Yes 1 No 40
18 F II 21651 80 110 82 110 84 130 No 14 No No 2 No 60
19 F II 28236 80 120 82 120 82 130 No 14 No No 1 No 55
20 F II 25294 80 120 80 120 82 110 No 14 No Yes 1 No 50
21 F II 28884 90 110 92 110 92 120 No 14 No No 1 No 45
22 F II 47407 113 130 100 130 90 120 Yes 18 No No 1 No 75
23 F II 48405 102 110 90 100 90 120 No 20 No No 2 No 55
24 F II 49091 80 110 80 100 80 110 No 14 No No 1 No 25
25 F II 43123 84 120 86 130 86 130 No 12 No No 1 No 50
ABBREVIATIONS
DM - Diabetes Mellitus 
HT   - Hyper Tension
IHT - Ischeamic Heart Disease
COPD- Chronic Obstructive Pulmonary Disease
PR - Pulse Rate
RR - Respiratory Rate
BP-S - Blood Pressure Systolic 
BP-D - Blood Pressure Diastolic 
MSL - Maximum Sensory Level
TMSL- Time of Maximum Sensory Level
GMB - Grading of Motor Block
ISB - Incomplete Sensory Block
NV - Nausea, Vomiting 
2 SR Time - Two segment Regression Time   
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